Pancreas-specific PDX1-Cre or P48-Cre knockdown of SMAD4/DPC4 significantly promoted KRASG12D [78] activation or PTEN [79] inactivation, triggering tumour progression. This evidence concerns the gene PTEN and neoplasm.